On 2025-05-12, Hoth Therapeutics, Inc. (HOTH) announced earnings per share of $-0.27 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.34.
The next expected annoucement date for quarterly earnings is 2025-08-08, with an average estimated earnings per share of $-0.27 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.34 | $-0.27 |
| 2025-03-28 | 2024-12-31 | $-0.39 | $-0.32 |
| 2024-11-12 | 2024-09-30 | $-0.30 | $-0.31 |
| 2024-08-09 | 2024-06-30 | $-0.39 | $-0.24 |
| 2024-05-14 | 2024-03-31 | $-0.43 | $-0.46 |
| 2024-03-28 | 2023-12-31 | -- | $-0.31 |
| 2023-11-13 | 2023-09-30 | -- | $-0.60 |
| 2023-08-11 | 2023-06-30 | -- | $-0.57 |
| 2023-05-15 | 2023-03-31 | -- | $-0.88 |
| 2023-03-31 | 2022-12-31 | -- | $-2.72 |
| 2022-11-10 | 2022-09-30 | -- | $-2.05 |
| 2022-08-12 | 2022-06-30 | -- | $-2.25 |
| 2022-05-12 | 2022-03-31 | -- | $-2.75 |
| 2022-03-30 | 2021-12-31 | -- | $-3.50 |
| 2021-11-10 | 2021-09-30 | $-3.75 | $-3.50 |
| 2021-08-11 | 2021-06-30 | $-4.50 | $-3.50 |
| 2021-05-13 | 2021-03-31 | -- | $-6.00 |
| 2021-03-16 | 2020-12-31 | -- | $-1.00 |
| 2020-11-10 | 2020-09-30 | -- | $-4.00 |
| 2020-08-13 | 2020-06-30 | $-3.50 | $-5.00 |
| 2020-05-13 | 2020-03-31 | $-4.25 | $-4.50 |
| 2020-03-02 | 2019-12-31 | -- | $-10.25 |
| 2019-11-12 | 2019-09-30 | $-2.50 | $-4.25 |
| 2019-08-14 | 2019-06-30 | -- | $-3.25 |
| 2019-05-15 | 2019-03-31 | -- | $-3.00 |